Medical News

RSS

Power of alpha wave increases just before the distracter

Alpha waves were long ignored, but gained interest of brain researchers recently. Electrical activity of groups of brain cells results in brain waves with different amplitudes. The so called alpha wave, a slow brain wave with a cycle of 100 milliseconds seems to play a key role in suppressing irrelevant brain activity. The current hypothesis is that this alpha wave is associated with pulses of inhibition (every 100 ms) in the brain.

8 Oct 2012

High levels of chronic and acute illnesses in Palestinian refugees

New research draws attention to the continuing and urgent health emergency facing Palestinians living under occupation, especially the health and wellbeing issues surrounding refugees from the occupied Palestinian territories. Abstracts of the research, which were presented at the fourth meeting of The Lancet Palestinian Health Alliance in March 2012, are published online in The Lancet.

8 Oct 2012

New neuroprotective agent for stroke patients potentially found

Scientists have shown that a drug called NA-1 results in fewer brain lesions in patients who have undergone surgery to repair a brain aneurysm, compared to placebo, and appears to be safe to use, according to an Article published Online First in The Lancet Neurology.

8 Oct 2012

CSIS report examines current, planned interventions aimed at improving maternal health

The Center for Strategic & International Studies (CSIS) on Friday released a report (.pdf) titled "Improving Maternal Mortality and Other Aspects of Women's Health," the center reports on its webpage.

8 Oct 2012

Merck receives non-exclusive license to use Delphi StabyExpress technology

Delphi Genetics SA has announced today a broad licensing agreement with a subsidiary of Merck & Co., Inc., known as MSD outside the United States and Canada, for the use of the StabyExpress technology, which allows high yield, cost effective protein expression without the use of antibiotics.

8 Oct 2012

Southern African leaders sign declaration on TB in mining sector

"In an attempt to tackle tuberculosis [TB] among current and former miners, their families, and affected communities, 15 southern African leaders signed a Declaration on TB in the Mining Sector, a legal instrument, at the recent summit meeting of the Southern African Development Community (SADC) Heads of State and Government in Maputo, Mozambique," the Lancet reports.

8 Oct 2012

Run for Healthy Heart attracts over 2,000 participants

In association with the Billion Hearts Beating Foundation, Indraprastha Apollo Hospitals organised a 5-km run titled 'Dil ki Daud'. In the wee hours of Sunday, more than 2,000 people participated in the 5-km run, which kicked off at 6:45 am. India's first blade runner and Kargil War amputee hero Retd. Major Devender Pal Singh - also participated in order to encourage the runners for a healthy living.

8 Oct 2012

ImaginAb enters into neurodegeneration research collaboration agreement with Lundbeck

ImaginAb, Inc., a clinical-stage company developing in vivo molecular imaging agents based on antibody fragment technology, today announced that it has entered into a collaboration and commercialization agreement with H. Lundbeck A/S.

8 Oct 2012

ADI introduces octal ultrasound receiver with on-chip JESD204B serial interface

Analog Devices, Inc., the leading provider of data-conversion technology and longtime collaborator with the medical imaging industry, today introduced the industry's first octal ultrasound receiver to feature an on-chip JESD204B serial interface.

8 Oct 2012

Loose oversight may be to blame in meningitis outbreak

The rising toll - 7 dead, 57 ill and thousands potentially exposed - has cast a harsh light on the loose regulations that legal experts say allowed a company to sell 17,676 vials of an unsafe drug to pain clinics in 23 states.

8 Oct 2012

Sir John B. Gurdon and Shinya Yamanaka have won the 2012 Nobel Prize in Physiology or Medicine

The 2012 Nobel Prize in Physiology or Medicine has been awarded jointly to Sir John B. Gurdon and Shinya Yamanaka for the discovery that mature cells can be reprogrammed to become pluripotent.

8 Oct 2012

NovaSom launches full-service testing program for pre-operative diagnosis of OSA

NovaSom, Inc., the leader in home sleep testing and cost-saving solutions for Obstructive Sleep Apnea (OSA) management, today announces the launch of AccuSom Safe Recovery.

8 Oct 2012

Trellis, OMT enter collaboration to generate human antibodies

Trellis Bioscience LLC and Open Monoclonal Technology, Inc. today announced a new collaboration where the companies will join forces to generate human antibodies against therapeutic targets identified by Trellis and its partners using OMT's OmniRat platform.

8 Oct 2012

More toilets would help save lives in India

The controversy in India over "a self-evident statement by the rural development minister that India needs toilets more than it does temples ... is a perfect example of the stupidity that too often dominates Indian politics," GlobalPost senior correspondent Jason Overdorf writes in his blog "On India."

8 Oct 2012

Standard red blood cell transfusion as good as fresh RBCs for premature infants

Among premature, very low-birth-weight infants requiring a transfusion, use of fresh red blood cells (RBCs) compared with standard RBC transfusion practice did not improve clinical outcomes that included rates of complications or death, according to a study in the October 10 issue of JAMA.

8 Oct 2012

NCI awards Cellerant SBIR contract to develop Megakaryocyte Progenitor Cell therapy for thrombocytopenia

Cellerant Therapeutics Inc., a biotechnology company developing novel hematopoietic stem cell-based cellular and antibody therapies for blood disorders and cancer, announced today that it has been awarded a Small Business Innovation Research (SBIR) Phase 1 contract and a Phase 2 option from the National Cancer Institute (NCI) valued up to $1,683,503.

8 Oct 2012

Trevena reports completion of TRV027 Phase 2a study in advanced heart failure patients

Trevena, Inc., the leader in the discovery and development of G-protein coupled receptor (GPCR) biased ligands, today announced that it has successfully completed a Phase 2a study on the hemodynamic effects of TRV027 in patients with advanced heart failure with reduced ejection fraction.

8 Oct 2012

UnitedHealth to buy Brazilian health insurer

UnitedHealth Group Inc., the biggest U.S. health insurance company, agreed to pay about $4.9 billion to buy 90 percent of Amil Participacoes SA (AMIL3), a Brazil-based insurer and hospitals operator that gives the American company a stake in the world's second-biggest emerging economy.

8 Oct 2012

Positive results from Cempra's IV solithromycin Phase 1 study

Cempra, Inc., a clinical-stage pharmaceutical company focused on developing antibiotics to meet critical medical needs in the treatment of bacterial infectious diseases, today announced results of its Phase 1 study of intravenous (IV) solithromycin in healthy subjects. The study demonstrated that IV solithromycin was well tolerated, showed a favorable pharmacokinetic profile (PK) and achieved relevant plasma concentrations.

8 Oct 2012

New legislation proposed to improve seniors' care coordination

The bill backed by Rep. Allyson Schwartz, D-Pa., and Sen. John Kerry, D-Mass., would promote better coordination between medical and social services for elderly people by building on the Older Americans Act.

8 Oct 2012